City

Andover (1)

Newport Beach (1)

Waterloo (1)

Condition

Ophthalmic Solutions (3)

Aceclidine (1)

Brimonidine Tartrate (1)

Eye Diseases (1)

Glaucoma (1)

Presbyopia (1)

Refractive Errors (1)

Overall Status

Completed (2)

Recruiting (1)

Sign in for free

Phase

early phase 1 (1)

phase 1 (1)

phase 3 (1)

Sponsor

Johnson & Johnson Consumer Inc. (J&JCI) (1)

LENZ Therapeutics, Inc (1)

University of Waterloo (1)

Collaborator

ORA, Inc. (1)

Intervention

aceclidine (1)

aceclidine + brimonidine (1)

f# 13418-148 eye drops (1)

f# pf-004390 eye drops (1)

f#13418-158 eye drops (1)

timolol maleate 0.5% ophthalmic solution (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

ophthalmic solutions

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Eye Diseases, Presbyopia, Refractive Errors Trial in Newport Beach (Aceclidine + Brimonidine, Aceclidine)

Recruiting

Eye Diseases
+5 more

Aceclidine + Brimonidine
Aceclidine

Newport Beach, California

Site #101

Jul 7, 2023

Ophthalmic Solutions Trial in Andover (F# 13418-148 Eye Drops, F#13418-158 Eye Drops, F# PF-004390 Eye Drops)

Completed

Has Results

Ophthalmic Solutions

F# 13418-148 Eye Drops
+2 more

Andover, Massachusetts

Andover Eye Associates

Aug 24, 2018

Ophthalmic Solutions, Glaucoma Trial in Waterloo (Timolol maleate 0.5% ophthalmic solution)

Completed

Ophthalmic Solutions
Glaucoma

Timolol maleate 0.5% ophthalmic solution

Waterloo, Ontario, Canada

University of Waterloo

Jan 19, 2018